Meetings - The ASCO Post

This is Part 3 of Treatment Sequencing Considerations for Chronic Graft-vs-Host Disease, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this vid...

hematologic malignancies

/ Treatment Sequencing Considerations for Chronic Graft-vs-Host Disease

Case 2: Moderate Chronic GVHD

This is Part 2 of Treatment Sequencing Considerations for Chronic Graft-vs-Host Disease, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this vid...

hematologic malignancies

/ Treatment Sequencing Considerations for Chronic Graft-vs-Host Disease

Case 1: Acute GVHD in a Patient With Lymphoma

This is Part 1 of Treatment Sequencing Considerations for Chronic Graft-vs-Host Disease, a three-part video roundtable series. Scroll down to watch the other videos from this roundtable. In this vid...

Treatment Sequencing Considerations for Chronic Graft-vs-Host Disease

Case 3: Steroid-Refractory Chronic GVHD With Sclerosis

Case 2: Moderate Chronic GVHD

Case 1: Acute GVHD in a Patient With Lymphoma

Hereditary Ovarian Cancer Risk Unlocking New Insights

CheckMate 7FL Neoadjuvant Immunochemotherapy in ER-Positive, HER2-Negative Breast Cancer

TACE and Durvalumab/Bevacizumab in Unresectable HCC

Does Brain MRI Surveillance Benefit Asymptomatic Patients With Stage IV Breast Cancer

BOREAS Trial Navtemadlin Demonstrates Clinical Benefit in JAK Inhibitor–Refractory Myelofibrosis